GSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma.
Kang L, Liu Y, He J, Wang Y, Xue M, Wu X, Wang Z, Zhang Y, Chu M, Li J, Wei W, Li J, Li E, Liao L, Xiao J, Zhang R, Xu L, Wong J.
Kang L, et al. Among authors: xue m.
Oncogene. 2023 Jul;42(30):2297-2314. doi: 10.1038/s41388-023-02748-w. Epub 2023 Jun 22.
Oncogene. 2023.
PMID: 37349645